Cargando…

Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma

PURPOSE: The goals of our study were (a) to validate a molecular expression signature (cell cycle progression [CCP] score and molecular prognostic score [mPS; combination of CCP and pathological stage {IA or IB}]) that identifies stage I lung adenocarcinoma (ADC) patients with a higher risk of cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eguchi, Takashi, Kadota, Kyuichi, Chaft, Jamie, Evans, Brent, Kidd, John, Tan, Kay See, Dycoco, Joe, Kolquist, Kathryn, Davis, Thaylon, Hamilton, Stephanie A., Yager, Kraig, Jones, Joshua T., Travis, William D., Jones, David R., Hartman, Anne-Renee, Adusumilli, Prasad S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085225/ https://www.ncbi.nlm.nih.gov/pubmed/27153551 http://dx.doi.org/10.18632/oncotarget.9129

Ejemplares similares

Prognostic value of the immune microenvironment in lung adenocarcinoma
por: Kadota, Kyuichi, et al.
Publicado: (2013)

Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration
por: Kadota, Kyuichi, et al.
Publicado: (2015)

Small RNA Sequencing for Profiling MicroRNAs in Long-Term Preserved Formalin-Fixed and Paraffin-Embedded Non-Small Cell Lung Cancer Tumor Specimens
por: Buitrago, Daniel H., et al.
Publicado: (2015)

Reporting net survival in populations: a sensitivity analysis in lung cancer demonstrates the differential implications of reporting relative survival and cause-specific survival
por: Tan, Kay See, et al.
Publicado: (2019)

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance
por: Takahashi, Yusuke, et al.
Publicado: (2018)

Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
por: Eguchi, Takashi, et al.
Publicado: (2017)

Competing risks and cancer-specific mortality: why it matters
por: Tan, Kay See, et al.
Publicado: (2017)

Current status and perspectives of spread through air spaces in lung cancer
por: Ikeda, Toshihiro, et al.
Publicado: (2021)

Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review
por: Chen, Monica F., et al.
Publicado: (2023)

Two cases of nodular smooth muscle proliferation suspected of primary lung cancer from preoperative images: a case report
por: Ikeda, Toshihiro, et al.
Publicado: (2020)

Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection
por: Yoshida, Chihiro, et al.
Publicado: (2022)

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
por: Rosner, Samuel, et al.
Publicado: (2023)

Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients
por: Kanaji, Nobuhiro, et al.
Publicado: (2019)

Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes
por: Choe, Jennie K., et al.
Publicado: (2022)

Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations
por: Rekhtman, Natasha, et al.
Publicado: (2017)

RNF128 expression in lung adenocarcinoma is a favorable prognostic factor associated with decreased tumor‐associated macrophages
por: Fujimoto, Syuusuke, et al.
Publicado: (2023)

The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists
por: Cockerell, Clay J., et al.
Publicado: (2016)

Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma
por: Caso, Raul, et al.
Publicado: (2021)

Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
por: Restle, David, et al.
Publicado: (2023)

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma
por: Bueno, Raphael, et al.
Publicado: (2015)

Primary lung cancer in women after previous breast cancer
por: Nobel, Tamar B, et al.
Publicado: (2022)

Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
por: Tozbikian, Gary, et al.
Publicado: (2014)

A CASE OF LUNG ABSCESS
por: Kidd, Cecil
Publicado: (1938)

Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA
por: Tsuboi, Masahiro, et al.
Publicado: (2021)

Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal Carcinoma
por: Morinishi, Tatsuya, et al.
Publicado: (2019)

CCP1, a Regulator of Tubulin Post-Translational Modifications, Potentially Plays an Essential Role in Cerebellar Development
por: Pang, Bo, et al.
Publicado: (2023)

Devising Assisted Reproductive Technologies for Wild-Derived Strains of Mice: 37 Strains from Five Subspecies of Mus musculus
por: Mochida, Keiji, et al.
Publicado: (2014)

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
por: Jones, Gregory D., et al.
Publicado: (2021)

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab
por: Lebow, Emily S., et al.
Publicado: (2023)

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab
por: Shaverdian, Narek, et al.
Publicado: (2020)

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer
por: Luo, Leo Y., et al.
Publicado: (2020)

Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-Ras(V12) and Loss of p53
por: Hall, Emily H., et al.
Publicado: (2014)

Sources of Marital Conflict in Five Cultures
por: Dillon, Lisa M., et al.
Publicado: (2015)

Tumor response from durvalumab (MEDI4736) + tremelimumab treatment in patients with advanced non-small cell lung cancer (NSCLC) is observed regardless of PD-L1 status
por: Rizvi, Naiyer, et al.
Publicado: (2015)

Sansoninto-induced Lung Injury
por: Komiya, Kosaku, et al.
Publicado: (2022)

Solitary costal plasmacytoma mimicking lung cancer metastasis
por: Kadota, Naoki, et al.
Publicado: (2017)

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
por: Paik, Paul K., et al.
Publicado: (2022)

Lessons Learned to Promote Lung Cancer Screening and Preempt Worsening Lung Cancer Disparities
por: Burnett-Hartman, Andrea N., et al.
Publicado: (2020)

Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy
por: Li, Xiaoyu, et al.
Publicado: (2019)

A prospective trial of intraoperative tissue oxygenation measurement and its association with anastomotic leak rate after Ivor Lewis esophagectomy
por: Adusumilli, Prasad S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a04e2brbt8iikg3dl6i4r456uu